There are many oncology pathology organizations around the world that offer essential resources, networking opportunities, and sometimes even free Continuing Medical Education (CME) credits. These groups are for everyone, from…
Get ready for an insightful conversation on how digital platforms are revolutionizing pathology education. In this episode of PathPulse, host James Thackeray welcomes a true trailblazer, Dr. Kamran Mirza, Professor…
Lumea and Valar Labs today announced a partnership to integrate Valar Labs’ Vesta tests into the Lumea digital pathology platform. LEHI, UT, UNITED STATES, October 9, 2025 /EINPresswire.com/ — Lumea,…
LEHI, UT –October 6, 2025– Lumea, a leader in digital pathology solutions, has been named the Healthcare Tech Innovator of the Year 2025 – Western USA and the Leading Provider…
In this episode of PathPulse, we’re joined by Dr. Syed Hoda, a self-described ordinary pathologist who faced an extraordinary challenge. With no prior experience in informatics or digital pathology, Dr….
Join Lumea Monthly, the premier digital pathology newsletter that helps you stay up to date with the latest in digital pathology tech, events, and practical applications! Sign up now to…
The 2025 Digital Diagnostic Summit begins Sunday, September 28, at the St Regis Resort in Park City, Utah! This exclusive conference focuses on “Climbing the Summit of Digital Pathology.” Together,…
Lumea is recognized on the Utah Business Fast 50 list for its digital pathology tech, reinforcing its role as a leader in Utah’s innovative business landscape. LEHI, UT, UNITED STATES,…
Get ready, histotechs! The National Society for Histotechnology (NSH) Convention is back, and this year it’s happening from September 20-24, 2025, at the New Orleans Convention Center. It’s the must-attend…
This year’s DDx Summit is gearing up to be our best yet! Make sure you’re ready for success with our best tips on getting the most out of the event….
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
